Abstract
This report:
- Details the complicated world of substance abuse including stimulants such
as tobacco, amphetamines, cocaine and crack, depressants such as sedatives and
hypnotics, alcohol and opiates, and hallucinogens
- Identifies therapeutics and diagnostics for drug abuse treatment and makes
U.S. market forecasts for these products over a 5-year period, from 2008 to
the end of 2013
- Includes current and potential market drivers
- Discusses up-and-coming products that may make a significant contribution
to the market
- Profiles market participants and looks at market shares.
STUDY GOALS AND OBJECTIVES
This BCC Research report details the complicated world of substance abuse. The
increased prevalence of substance abuse poses a threat to the health and
welfare of many populations throughout the world. Recreational drugs play a
major role in crime and corruption and are becoming a larger problem each
year. Abuse of prescription drugs and alcohol places a heavy burden on health
resources due to the subsequent medical problems. Breaking the substance abuse
cycle is a difficult and tedious process. Pharmaceutical manufacturers have
developed several products to assist in recovery from substance abuse. Those
products are detailed in the report. Also discussed are the products to help
employers, parents, social workers, and other groups and organizations detect
for substance abuse.
The objectives of the study are to heighten the awareness of drug abuse and to
identify preparations, tests, and important advancements in the drug abuse
treatment arena. The study analyzes the new therapeutics and diagnostics for
drug abuse treatment from a current standpoint as well as what is on the
horizon. Manufacturers of pharmaceutical products have been reluctant to
invest valuable time and resources into this market because of the issues
facing the market. As a result, the problem of drug abuse continues to grow.
SCOPE OF REPORT
The study is designed to be a comprehensive business tool that provides an
in-depth look at the world of substance abuse treatments and diagnostics. The
geographic scope of the report is the United States. The report identifies the
different drugs of addiction; gives a brief explanation of the drug; outlines
the characteristics of the drug; cites complications of the drug; presents
current diagnostic testing; outlines current treatments, market size, and
market participants; and discusses new developments and research. The report
describes the industry in detail, its relationship to the healthcare industry,
its economic consequences, its participants, and its trends for the future.
The following areas are addressed in this report:
- Stimulants
- Tobacco
- Amphetamines
- Cocaine, Crack
- Depressants
- Sedatives and Hypnotics
- Alcohol
- Opiates
- Hallucinogens
- Diagnostic Testing
Each subsegment is discussed in detail, describing the drug, complications,
diagnostic testing, therapeutic management, and current products on the market
to treat abuse of the drug.
INFORMATION SOURCES
The information and analysis presented in this BCC Research report are based
on extensive firsthand interviews with primary executives, product managers,
and clinical specialists in the area of addiction and substance abuse.
Background information was obtained from various government, business, medical
journal, psychiatric journal and trade magazines; from statistics from the
National Center on Drug Abuse; and from interviews with psychiatrists,
psychologists, drug treatment counselors, and nurses. Key information from
published literature was used to conduct interviews with industry participants
to validate and obtain expert opinions on current and future trends.
Interviews were also used to confirm and/or adjust market size and market
share estimates, as well as to formulate market projections.
All market data pertain to the U.S. market at the manufacturer' s level. Data
are expressed in 2008 U.S. dollars. The base year was 2007. Historical data
are provided for 2006 and forecast data are provided for 2008 and 2013.
Historical, base year and forecast data are provided for each market segment
and subsegment. Market shares are provided for each market segment for the
2007 base year.
|